Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients

NCT05502081 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

265

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Casirivimab and Imdevimab Drug Combination
DRUG: Remdesivir
DRUG: Favipiravir

Sponsor

Mansoura University Hospital